Literature DB >> 23322284

Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome.

Pratip Chakraborty1, Sanghamitra Ghosh, S K Goswami, Syed N Kabir, Baidyanath Chakravarty, Kuladip Jana.   

Abstract

Insulin resistance is a very common associate of polycystic ovary syndrome (PCOS). Pathophysiology in relation with the essential elements including copper, magnesium, zinc, manganese, chromium, and calcium has been reported in women with insulin resistance. This prospective study was designed to explore whether the women with PCOS do exhibit altered serum element levels in association with/without insulin resistance. One hundred and thirty-two women with PCOS and forty-six control women were studied. Women with PCOS were further divided based on the presence of insulin resistance (insulin resistant: n = 50; non-insulin resistant: n = 82). In all women, basal levels of gonadotropins, prolactin, testosterone, insulin, glucose, and the six different elements were measured. Serum levels of testosterone (p < 0.001), luteinizing hormone (p < 0.05), and fasting insulin (p < 0.004) were significantly higher in the PCOS population compared to controls as well as PCOS women without insulin resistance. Women with PCOS exhibited a significantly high calcium (p < 0.04) and lower manganese levels (p < 0.002) when compared to controls. However, the PCOS women with insulin resistance exhibited significantly lower serum levels of magnesium and chromium (p < 0.04), in addition to higher levels of zinc and copper (p < 0.04). The differences in calcium (p < 0.03) and manganese levels (p < 0.0001) became aggravated with the presence of insulin resistance when compared to control as well as PCOS women without insulin resistance. In PCOS-associated insulin resistance, circulating serum magnesium (r = -0.31; p < 0.03) and chromium (r = -0.38; p < 0.006) status significantly correlated with fasting insulin levels. We conclude that imbalanced element status may be a key foundation for insulin resistance in PCOS. The findings in this study should be investigated with further trials in order to obtain new insights into PCOS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23322284     DOI: 10.1007/s12011-012-9592-5

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  20 in total

1.  Dietary minerals, reproductive hormone levels and sporadic anovulation: associations in healthy women with regular menstrual cycles.

Authors:  Keewan Kim; Jean Wactawski-Wende; Kara A Michels; Karen C Schliep; Torie C Plowden; Ellen N Chaljub; Sunni L Mumford
Journal:  Br J Nutr       Date:  2018-04-20       Impact factor: 3.718

Review 2.  Associations Between Serum Magnesium Concentrations and Polycystic Ovary Syndrome Status: a Systematic Review and Meta-analysis.

Authors:  Maedeh Babapour; Hamed Mohammadi; Maryam Kazemi; Amir Hadi; Mahsa Rezazadegan; Gholamreza Askari
Journal:  Biol Trace Elem Res       Date:  2020-08-18       Impact factor: 3.738

3.  Effects of Melatonin and/or Magnesium Supplementation on Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Reihaneh Mousavi; Mohammad Alizadeh; Mohammad Asghari Jafarabadi; Lida Heidari; Roshan Nikbakht; Hossein Babaahmadi Rezaei; Majid Karandish
Journal:  Biol Trace Elem Res       Date:  2021-05-19       Impact factor: 3.738

4.  Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome.

Authors:  Trine Maxel; Pernille Fog Svendsen; Kamille Smidt; Jesper Krogh Lauridsen; Birgitte Brock; Steen Bønlykke Pedersen; Jørgen Rungby; Agnete Larsen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-02       Impact factor: 5.555

5.  Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Mohammad Alizadeh; Majid Karandish; Mohammad Asghari Jafarabadi; Lida Heidari; Roshan Nikbakht; Hossein Babaahmadi Rezaei; Reihaneh Mousavi
Journal:  Nutr Metab (Lond)       Date:  2021-06-06       Impact factor: 4.169

6.  The Content of Minerals in the PCOS Group and the Correlation with the Parameters of Metabolism.

Authors:  Kamila Pokorska-Niewiada; Agnieszka Brodowska; Małgorzata Szczuko
Journal:  Nutrients       Date:  2021-06-28       Impact factor: 5.717

7.  Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance.

Authors:  Pratip Chakraborty; S K Goswami; Shweta Rajani; Sunita Sharma; Syed N Kabir; Baidyanath Chakravarty; Kuladip Jana
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

8.  Impact of methimazole treatment on magnesium concentration and lymphocytes activation in adolescents with Graves' disease.

Authors:  Maria Klatka; Ewelina Grywalska; Malgorzata Partyka; Malgorzata Charytanowicz; Jacek Rolinski
Journal:  Biol Trace Elem Res       Date:  2013-05-11       Impact factor: 3.738

9.  Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.

Authors:  Pratip Chakraborty; Sayani Banerjee; Piyali Saha; Shyam Sundar Nandi; Sunita Sharma; Sourendra K Goswami; Baidyanath Chakravarty; Syed N Kabir
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

10.  Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome.

Authors:  Xi Luo; Wang-Yu Cai; Hong-Li Ma; Jing Cong; Hui Chang; Jing-Shu Gao; Wen-Juan Shen; Yu Wang; Xin-Ming Yang; Xiao-Ke Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.